Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2024

Open Access 01-12-2024 | Rheumatoid Arthritis | Research

Optical imaging (HandScan) can identify ultrasound remission in rheumatoid arthritis

Authors: Charline Rinkin, Olivier Malaise, Florane Chauveheid, Caroline Gerard, Laurence Seidel, Michel Malaise, Clio Ribbens

Published in: BMC Musculoskeletal Disorders | Issue 1/2024

Login to get access

Abstract

Background

Identifying remission is of high importance in rheumatoid arthritis (RA) because remission is associated with less structural progression. We investigated the efficacy of a new optical imaging device, HandScan, to identify RA remission, as defined by ultrasound (US).

Methods

61 RA patients were included. Disease activity was evaluated by clinical assessment and US, using gray-scale (GS) and Power Doppler (PD). HandScan determined unitary optical spectral transmission (OST) values for wrists, metacarpophalangeal and proximal interphalangeal joints. At the patient level, three composite HandScan (HS) scores were calculated: total HS score; disease activity score OST (DAS-OST) and DAS-OST without patient global assessment (PtGA). Using ROC curves, we determined HS cut-offs to identify US-defined remission.

Results

At the joint level, unitary OST values significantly correlated with GS synovitis [odds ratio (OR) 2.43, p < 0.0001] and PD positivity (OR 3.72, p = 0.0002 ). At the patient level, total HS score and DAS-OST were significantly associated with all gray-scale US (GSUS) and power doppler US (PDUS) parameters evaluated (synovitis number and grade, synovial thickness, PD grade) (p < 0.05). The cut-off to identify US-defined remission at the joint level was of 0.92, giving an 81% sensitivity and a 96% positive predictive value (PPV). At the patient level, ROC-curves failed to identify a robust cut-off for the total HS score, but did identify a cut-off (3.68) for DAS-OST to identify US-defined remission, but with lower sensitivity (75%), specificity (56%) and PPV (67%).

Conclusions

HandScan is a non-invasive optical imaging technique providing OST values that correlate with GSUS and PDUS parameters. In addition, HandScan is able to reliably identify US-defined remission in RA at the joint level, with a good sensitivity and high PPV. At the patient level, HandScan DAS-OST can also determine US remission (while total HS score failed to do so), but with lower performance.
Appendix
Available only for authorised users
Literature
2.
go back to reference Szkudlarek M, Klarlund M, Narvestad E, Court-Payen M, Strandberg C, Jensen KE, Thomsen HS, Østergaard M. Ultrasonography of the metacarpophalangeal and proximal interphalangeal joints in rheumatoid arthritis: a comparison with magnetic resonance imaging, conventional radiography and clinical examination. Arthritis Res Ther. 2006;8. https://doi.org/10.1186/ar1904 Szkudlarek M, Klarlund M, Narvestad E, Court-Payen M, Strandberg C, Jensen KE, Thomsen HS, Østergaard M. Ultrasonography of the metacarpophalangeal and proximal interphalangeal joints in rheumatoid arthritis: a comparison with magnetic resonance imaging, conventional radiography and clinical examination. Arthritis Res Ther. 2006;8. https://​doi.​org/​10.​1186/​ar1904
3.
go back to reference Filippou G, Sakellariou G, Scirè CA, Carrara G, Rumi F, Bellis E, Adinolfi A, Batticciotto A, Bortoluzzi A, Cagnotto G, et al. The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: the STA. Ann Rheum Dis. 2018;77:1283–9. https://doi.org/10.1136/annrheumdis-2018-213217CrossRefPubMed Filippou G, Sakellariou G, Scirè CA, Carrara G, Rumi F, Bellis E, Adinolfi A, Batticciotto A, Bortoluzzi A, Cagnotto G, et al. The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: the STA. Ann Rheum Dis. 2018;77:1283–9. https://​doi.​org/​10.​1136/​annrheumdis-2018-213217CrossRefPubMed
5.
6.
go back to reference Verhoeven MMA, Tekstra J, Marijnissen ACA, Meier AJL, Westgeest AAA, Lafeber FPJG, Jacobs JWG, Van Laar JM, Welsing PMJ. Utility of the HandScan in monitoring disease activity and prediction of clinical response in rheumatoid arthritis patients: an explorative study. Rheumatol Adv Pract. 2021;5. https://doi.org/10.1093/rap/rkab004 Verhoeven MMA, Tekstra J, Marijnissen ACA, Meier AJL, Westgeest AAA, Lafeber FPJG, Jacobs JWG, Van Laar JM, Welsing PMJ. Utility of the HandScan in monitoring disease activity and prediction of clinical response in rheumatoid arthritis patients: an explorative study. Rheumatol Adv Pract. 2021;5. https://​doi.​org/​10.​1093/​rap/​rkab004
7.
go back to reference Hasan AA, Reimann F, Veeger NJGM, Bergstra SA, Zhang D, Bourgonje AR, Hendriks L, Beertsen T, Riofrio LZ, Wink F, Schilder A, Huizinga TWJ, Bos R. Optical imaging compared to clinical examination in 484 rheumatoid arthritis patients: the Leeuwarden Handscan Registry. Rheumatol Int. 2022;42(11):2019–26. https://doi.org/10.1007/s00296-021-05060-6. Epub 2022 Jan 27. PMID: 35083506.CrossRefPubMed Hasan AA, Reimann F, Veeger NJGM, Bergstra SA, Zhang D, Bourgonje AR, Hendriks L, Beertsen T, Riofrio LZ, Wink F, Schilder A, Huizinga TWJ, Bos R. Optical imaging compared to clinical examination in 484 rheumatoid arthritis patients: the Leeuwarden Handscan Registry. Rheumatol Int. 2022;42(11):2019–26. https://​doi.​org/​10.​1007/​s00296-021-05060-6. Epub 2022 Jan 27. PMID: 35083506.CrossRefPubMed
8.
go back to reference Verhoeven MMA, Westgeest AAA, Schwarting A, Jacobs JWG, Heller C, van Laar JM, Lafeber FPJG, Tekstra J, Triantafyllias K, Welsing PMJ. Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) scores. Arthritis Care Res. 2022;74:1493–9. https://doi.org/10.1002/acr.24607CrossRef Verhoeven MMA, Westgeest AAA, Schwarting A, Jacobs JWG, Heller C, van Laar JM, Lafeber FPJG, Tekstra J, Triantafyllias K, Welsing PMJ. Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) scores. Arthritis Care Res. 2022;74:1493–9. https://​doi.​org/​10.​1002/​acr.​24607CrossRef
10.
go back to reference Verhoeven MMA, Westgeest AAA, Tekstra J, van Laar JM, Lafeber FPJG, Welsing PMJ, Jacobs JWG. Classification of rheumatoid arthritis into active or inactive with a modified Disease Activity score, for future use as a treat-to-target tool, with a HandScan score replacing joint counts. Clin Exp Rheumatol. 2022;40(11):2018–22. https://doi.org/10.55563/clinexprheumatol/tpsngs. Epub 2022 Feb 17. PMID: 35200120.CrossRefPubMed Verhoeven MMA, Westgeest AAA, Tekstra J, van Laar JM, Lafeber FPJG, Welsing PMJ, Jacobs JWG. Classification of rheumatoid arthritis into active or inactive with a modified Disease Activity score, for future use as a treat-to-target tool, with a HandScan score replacing joint counts. Clin Exp Rheumatol. 2022;40(11):2018–22. https://​doi.​org/​10.​55563/​clinexprheumatol​/​tpsngs. Epub 2022 Feb 17. PMID: 35200120.CrossRefPubMed
13.
go back to reference Blanken AB, Korteweg M, van Boheemen L, van Vollenhoven RF, Nurmohamed MT, van der Laken CJ. Clinical evaluation of optical spectral transmission imaging for detection of disease activity in rheumatoid arthritis. Scand J Rheumatol. 2024;53(2):85–93. Epub 2023 Mar 28. PMID: 36974977.CrossRefPubMed Blanken AB, Korteweg M, van Boheemen L, van Vollenhoven RF, Nurmohamed MT, van der Laken CJ. Clinical evaluation of optical spectral transmission imaging for detection of disease activity in rheumatoid arthritis. Scand J Rheumatol. 2024;53(2):85–93. Epub 2023 Mar 28. PMID: 36974977.CrossRefPubMed
14.
go back to reference Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569–81. https://doi.org/10.1002/art.27584CrossRefPubMed Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569–81. https://​doi.​org/​10.​1002/​art.​27584CrossRefPubMed
15.
go back to reference Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol. 1982;9:789–93.PubMed Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol. 1982;9:789–93.PubMed
16.
go back to reference Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight‐joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 3844–4. Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight‐joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 3844–4.
18.
go back to reference Aletaha D, Nell VPK, Stamm T, Uffmann M, Pflugbeil S, Machold K, Smolen JS. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther. 2005;7. https://doi.org/10.1186/ar1740 Aletaha D, Nell VPK, Stamm T, Uffmann M, Pflugbeil S, Machold K, Smolen JS. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther. 2005;7. https://​doi.​org/​10.​1186/​ar1740
19.
go back to reference Felson DT, Smolen JS, Wells G, Zhang B, Van Tuyl LHD, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardieri S, et al. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis. 2011;70:404–13.CrossRefPubMed Felson DT, Smolen JS, Wells G, Zhang B, Van Tuyl LHD, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardieri S, et al. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis. 2011;70:404–13.CrossRefPubMed
21.
go back to reference Bruyn GA, Iagnocco A, Naredo E, Balint PV, Gutierrez M, Hammer HB, Collado P, Filippou G, Schmidt WA, Jousse-Joulin S, Mandl P, Conaghan PG, Wakefield RJ, Keen HI, Terslev L, D’Agostino MA, OMERACT Ultrasound Working Group. OMERACT definitions for Ultrasonographic Pathologies and Elementary lesions of Rheumatic disorders 15 years on. J Rheumatol. 2019;46(10):1388–93. https://doi.org/10.3899/jrheum.181095. Epub 2019 Feb 1. PMID: 30709946.CrossRefPubMed Bruyn GA, Iagnocco A, Naredo E, Balint PV, Gutierrez M, Hammer HB, Collado P, Filippou G, Schmidt WA, Jousse-Joulin S, Mandl P, Conaghan PG, Wakefield RJ, Keen HI, Terslev L, D’Agostino MA, OMERACT Ultrasound Working Group. OMERACT definitions for Ultrasonographic Pathologies and Elementary lesions of Rheumatic disorders 15 years on. J Rheumatol. 2019;46(10):1388–93. https://​doi.​org/​10.​3899/​jrheum.​181095. Epub 2019 Feb 1. PMID: 30709946.CrossRefPubMed
22.
go back to reference Rinkin C, Fosse P, Malaise O, Chapelier N, Horrion J, Seidel L, Albert A, Hustinx R, Malaise MG. Dissociation between 2-[18F]fluoro-2-deoxy-D-glucose positron emission computed tomography, ultrasound and clinical assessments in patients with non-severe rheumatoid arthritis, including remission. BMC Rheumatol. 2021;5(31). https://doi.org/10.1186/s41927-021-00196-1 Rinkin C, Fosse P, Malaise O, Chapelier N, Horrion J, Seidel L, Albert A, Hustinx R, Malaise MG. Dissociation between 2-[18F]fluoro-2-deoxy-D-glucose positron emission computed tomography, ultrasound and clinical assessments in patients with non-severe rheumatoid arthritis, including remission. BMC Rheumatol. 2021;5(31). https://​doi.​org/​10.​1186/​s41927-021-00196-1
24.
go back to reference Besselink NJ, Westgeest AAA, Klaasen R. et al. Novel optical spectral transmission (OST)-guided versus conventionally disease activity-guided treatment: study protocol of a randomized clinical trial on guidance of a treat-to-target strategy for early rheumatoid arthritis. Trials 20, 226 (2019). https://doi.org/10.1186/s13063-019-3285-8 Besselink NJ, Westgeest AAA, Klaasen R. et al. Novel optical spectral transmission (OST)-guided versus conventionally disease activity-guided treatment: study protocol of a randomized clinical trial on guidance of a treat-to-target strategy for early rheumatoid arthritis. Trials 20, 226 (2019). https://​doi.​org/​10.​1186/​s13063-019-3285-8
Metadata
Title
Optical imaging (HandScan) can identify ultrasound remission in rheumatoid arthritis
Authors
Charline Rinkin
Olivier Malaise
Florane Chauveheid
Caroline Gerard
Laurence Seidel
Michel Malaise
Clio Ribbens
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2024
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-024-07472-4

Other articles of this Issue 1/2024

BMC Musculoskeletal Disorders 1/2024 Go to the issue